Literature DB >> 7011799

Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor.

J Zapf, E Schoenle, M Waldvogel, I Sand, E R Froesch.   

Abstract

Trypsin-treatment of isolated rat adipocytes abolishes the metabolic effects not only of insulin, but also of the insulin-like growth factors: in trypsin-treated cells, concentrations of these hormones that are otherwise maximally effective no longer stimulate 3-O-methylglucose transport and lipogenesis or inhibit epinephrine induced lipolysis. Concomitantly, the trypsin-treated adipocytes no longer display specific insulin binding. In contrast, the characteristics of the binding of the insulin-like growth factors are not grossly affected by prior trypsinization of the adipocytes. These findings add further support to the concept that the insulin-like growth factors act on glucose metabolism and antilipolysis via the insulin receptor of the adipocyte.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011799     DOI: 10.1111/j.1432-1033.1981.tb05105.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  23 in total

1.  In vivo metabolic action of insulin-like growth factor I in adult rats.

Authors:  F Schmitz; H Hartmann; F Stümpel; W Creutzfeldt
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

2.  Glucocorticoids regulate the secretion of a 21kDa-IGF-binding protein by sheep adipose tissue explants.

Authors:  J Beattie; R G Vernon
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

Review 3.  The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

Authors:  R J Ross; J Rodriguez-Arnao; J Bentham; J H Coakley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

4.  Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E R Froesch
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Recombinant protein expression plasmids optimized for industrial E. coli fermentation and plant systems produce biologically active human insulin-like growth factor-1 in transgenic rice and tobacco plants.

Authors:  Mitra Panahi; Zaman Alli; Xiongying Cheng; Loubaba Belbaraka; Jaafar Belgoudi; Ravinder Sardana; Jenny Phipps; Illimar Altosaar
Journal:  Transgenic Res       Date:  2004-06       Impact factor: 2.788

6.  The effect of insulin-like growth factor II on glucose uptake and metabolism in rat skeletal muscle in vitro.

Authors:  S J Bevan; M Parry-Billings; E Opara; C T Liu; D B Dunger; E A Newsholme
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

Authors:  M A Hussain; O Schmitz; A Mengel; Y Glatz; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.

Authors:  M A Hussain; O Schmitz; A Mengel; A Keller; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Insulin-like growth factors and insulin: comparative aspects.

Authors:  E R Froesch; J Zapf
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

10.  Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

Authors:  J Zapf; E Futo; M Peter; E R Froesch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.